Saroja Pharma Industries India Ltd.

Financial

	Saroja Pharma Ind	Emmessar Biotech&Nut	Parmax Pharma
Operational Metrics
Financials
5 yr Average ROE	33.33 %	13.7 %	-1624.87 %
5yr average Equity Multiplier	4.66	1.24	46.04
5yr Average Asset Turnover Ratio	2.98	0.36	0.95
5yr Avg Net Profit Margin	2.08 %	71.53 %	-9.48 %
Price to Book	0.0	2.08	0.0
P/E	14.18	50.13	0.0
5yr Avg Cash Conversion Cycle	80.28 Days	68.18 Days	-161.05 Days
Inventory Days	11.27 Days	62.21 Days	73.65 Days
Days Receivable	122.72 Days	10.88 Days	40.27 Days
Days Payable	47.62 Days	199.95 Days	328.05 Days
5yr Average Interest Coverage Ratio	2.76	815.2	1.16
5yr Avg ROCE	37.65 %	19.97 %	-9.94 %
5yr Avg Operating Profit Margin	4.76 %	-101.39 %	3.93 %
5 yr average Debt to Equity	1.78	0.0	17.42
5yr CAGR Net Profit	3.81 %	0.0	n/a
5yr Average Return on Assets	6.13 %	10.86 %	-6.43 %
Shareholdings
Promoter Holding	73.02 %	59.53 %	30.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	1.02 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0